Top Five Articles on GenomeWeb Last Week: Illumina, Exact Sciences, Grail, and More

NEW YORK – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:

1. Illumina to Acquire Grail for $8B in Cash and Stock 
2. JP Morgan Downgrades Illumina to Neutral on Grail Deal 
3. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test 
4. UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal 
5. Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider